Diabetes drugs may be doing more than managing blood sugar, they could also shape cancer biology in unexpected ways.

This research delves into the association between anti-diabetic medications and cancer, exploring mechanisms beyond just ...

Medications developed to control blood sugar are now at the center of a very different scientific story: how they might raise ...

Brandee McKoon tried the traditional diets to lose weight but didn’t have much luck. The Kokomo woman was prediabetic when she asked her doctor about Ozempic, the popular anti-diabetic drug. Usually ...

Diabetes, particularly Type 2 Diabetes (T2DM), has been linked to an increased risk of various cancers, including liver, colorectal, and breast cancer.

Post-diagnostic hyperglycaemia in patients with bladder cancer is associated with poor cancer-specific and overall survival, a population-based cohort study shows.

In a recent study published in The Lancet EBioMedicine, a team of scientists used Mendelian Randomization analyses to explore whether antidiabetic medications could potentially be used as ...

Compared with insulin alone, oral antidiabetic drugs alone or in addition to insulin were associated with reduced fracture risks among patients with type 2 diabetes. Oral antidiabetic drugs (OADs) are ...

Among individuals with a diagnosis of type 2 diabetes across the United States, income level, hemoglobin A1c, and comorbidity burden were the primary patient-level drivers of the use of newer ...

Researchers at Case Western Reserve School of Medicine have found that, when compared to seven other anti-diabetic drugs, semaglutide, a popular diabetes and weight-loss drug, may lower the risk of ...

Most newly treated patients with type 2 diabetes exhibit suboptimal medication persistence, which is associated with higher risk of hospitalization and increased medical costs. Objectives: Medication ...